Shanghai Securities News China Securities Network News (reporter Luo Min) Luoxin Pharmaceutical announced that Shandong Luoxin Pharmaceutical Group Co., Ltd., a subsidiary of the company, recently received the "Notice of Approval of Drug Supplement Application for Drug Supplement" approved by the State Drug Administration, and the drug passed the consistency evaluation of the quality and efficacy of generic drugs. Meropenem is indicated for infections in adults and children caused by single or multiple bacteria susceptible to meropenem, and can be used alone or in combination with other antimicrobial agents to treat multiple infections.
![Haige Communications' latest announcement: Subsidiary pre-won the bid for China Mobile Communications Engineering Construction Service Collection and Procurement Project[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)